Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 USD | -8.33% | -21.99% | -26.67% |
04-19 | Bioxytran, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | Bioxytran, Inc. Announces Board Changes | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 21.85M 1.74B |
---|---|---|---|---|---|
Net income 2022 | -2M -159M | Net income 2023 | -4M -318M | EV / Sales 2022 | - |
Net Debt 2022 | 1.87M 149M | Net Debt 2023 | 1.9M 151M | EV / Sales 2023 | - |
P/E ratio 2022 |
-22.4
x | P/E ratio 2023 |
-4.7
x | Employees | 3 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 43.12% |
1 day | -8.33% | ||
1 week | -21.99% | ||
Current month | +3.97% | ||
3 months | -9.09% | ||
6 months | -36.05% | ||
Current year | -26.67% |
Managers | Title | Age | Since |
---|---|---|---|
David Platt
CEO | Chief Executive Officer | 71 | 28/02/18 |
Ola Soderquist
DFI | Director of Finance/CFO | 63 | - |
Leslie Ajayi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Platt
CEO | Chief Executive Officer | 71 | 28/02/18 |
Dale Conaway
BRD | Director/Board Member | 69 | 01/11/18 |
Anders Utter
BRD | Director/Board Member | 57 | 01/11/18 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 0.11 | -8.33% | 73 590 |
26/04/24 | 0.12 | -11.11% | 88,741 |
25/04/24 | 0.135 | +3.15% | 14,900 |
24/04/24 | 0.1309 | -10.36% | 239,093 |
23/04/24 | 0.146 | +3.55% | 121,400 |
Delayed Quote OTC Markets, April 29, 2024 at 04:50 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-26.67% | 21M | |
-2.56% | 103B | |
+1.76% | 95.28B | |
+1.46% | 22.15B | |
-15.71% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.71% | 16.05B | |
+5.65% | 13.68B | |
+34.44% | 12.17B |
- Stock Market
- Equities
- BIXT Stock